Celcius Launches Rs 500 Million Pharma Logistics Arm

18 Aug 2025 CW Team

In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.

To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.

Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”

Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.

The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.

Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Celcius Logistics, India’s leading tech-driven 3PL and cold supply chain provider, has launched Celcius+, a dedicated vertical for the seamless management of the pharmaceutical supply chain. The new arm is designed to meet the sector’s stringent demands for temperature control, compliance, and real-time visibility, ensuring safe and efficient transport of medicines, vaccines, and other sensitive products.In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Infrastructure Transport

06 Feb 2026

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Infrastructure Urban

06 Feb 2026

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Infrastructure Urban

06 Feb 2026

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..